These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33347825)

  • 1. Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in rats.
    Dela Peña I; Shen G; Shi WX
    Eur J Pharmacol; 2021 Feb; 892():173826. PubMed ID: 33347825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional profiling of SHR/NCrl prefrontal cortex shows hyperactivity-associated genes responsive to amphetamine challenge.
    Dela Peña IJI; Dela Peña I; de la Peña JB; Kim HJ; Sohn A; Shin CY; Han DH; Kim BN; Ryu JH; Cheong JH
    Genes Brain Behav; 2017 Sep; 16(7):664-674. PubMed ID: 28422445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common prefrontal cortical gene expression profiles between adolescent SHR/NCrl and WKY/NCrl rats which showed inattention behavior.
    Dela Peña I; Bang M; Lee J; de la Peña JB; Kim BN; Han DH; Noh M; Shin CY; Cheong JH
    Behav Brain Res; 2015 Sep; 291():268-276. PubMed ID: 26048425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
    Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theobromine improves hyperactivity, inattention, and working memory
    Matsuzaki K; Sugimoto N; Hossain S; Islam R; Sumiyoshi E; Hashimoto M; Kishi H; Shido O
    Food Funct; 2024 May; 15(10):5579-5595. PubMed ID: 38713055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens.
    Miller EM; Pomerleau F; Huettl P; Russell VA; Gerhardt GA; Glaser PE
    Neuropharmacology; 2012 Dec; 63(8):1327-34. PubMed ID: 22960443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro.
    Yoon SY; dela Peña I; Kim SM; Woo TS; Shin CY; Son KH; Park H; Lee YS; Ryu JH; Jin M; Kim KM; Cheong JH
    Arch Pharm Res; 2013 Jan; 36(1):134-40. PubMed ID: 23371806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing and delay discounting in attention-deficit/hyperactivity disorder: A translational approach.
    Fox AE; Nicholson AM; Singha D; Thieret BAS; Ortiz M; Visser EJ
    Dev Psychobiol; 2023 Jul; 65(5):e22399. PubMed ID: 37338253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of catalpol on behavior and neurodevelopment in an ADHD rat model.
    Yuan H; Ni X; Zheng M; Han X; Song Y; Yu M
    Biomed Pharmacother; 2019 Oct; 118():109033. PubMed ID: 31545235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder--lack of effect of methylphenidate.
    Warton FL; Howells FM; Russell VA
    Metab Brain Dis; 2009 Dec; 24(4):599-613. PubMed ID: 19821016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate and Atomoxetine-Responsive Prefrontal Cortical Genetic Overlaps in "Impulsive" SHR/NCrl and Wistar Rats.
    Dela Peña I; Dela Peña IJ; de la Peña JB; Kim HJ; Shin CY; Han DH; Kim BN; Ryu JH; Cheong JH
    Behav Genet; 2017 Sep; 47(5):564-580. PubMed ID: 28744604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics study of the prefrontal cortex in a rat model of attention deficit hyperactivity disorder reveals the association between cholesterol metabolism disorder and hyperactive behavior.
    Chen T; Yuan H; Sun YB; Song YC; Lu M; Ni X; Han X
    Biochem Biophys Res Commun; 2020 Mar; 523(2):315-321. PubMed ID: 31864712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
    Mc Fie S; Sterley TL; Howells FM; Russell VA
    Brain Res; 2012 Jul; 1467():91-103. PubMed ID: 22658977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum.
    Ruocco LA; Treno C; Gironi Carnevale UA; Arra C; Mattern C; Huston JP; de Souza Silva MA; Nikolaus S; Scorziello A; Nieddu M; Boatto G; Illiano P; Pagano C; Tino A; Sadile AG
    Amino Acids; 2014 Sep; 46(9):2105-22. PubMed ID: 24862315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
    Miller EM; Pomerleau F; Huettl P; Gerhardt GA; Glaser PE
    Psychopharmacology (Berl); 2014 Aug; 231(15):3019-29. PubMed ID: 24682500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
    Russell VA
    Behav Brain Res; 2002 Mar; 130(1-2):191-6. PubMed ID: 11864734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids/glucocorticoid receptors effect on dopaminergic neurotransmitters in ADHD rats.
    Chen Y; Zheng X; Xie L; Huang L; Ke Z; Zheng J; Lu H; Hu J
    Brain Res Bull; 2017 May; 131():214-220. PubMed ID: 28458039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and genetic evidence for a novel animal model of Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Subtype.
    Sagvolden T; Dasbanerjee T; Zhang-James Y; Middleton F; Faraone S
    Behav Brain Funct; 2008 Dec; 4():56. PubMed ID: 19046438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
    Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT
    Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupted Glutamatergic Transmission in Prefrontal Cortex Contributes to Behavioral Abnormality in an Animal Model of ADHD.
    Cheng J; Liu A; Shi MY; Yan Z
    Neuropsychopharmacology; 2017 Sep; 42(10):2096-2104. PubMed ID: 28176786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.